Disc Medicine, Inc./$IRON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Disc Medicine, Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Ticker
$IRON
Sector
Primary listing
Employees
154
Headquarters
Website
IRON Metrics
BasicAdvanced
$2.7bn
-
-$6.60
2.14
-
Price and volume
Market cap
$2.7bn
Beta
2.14
52-week high
$99.50
52-week low
$40.00
Average daily volume
468k
Financial strength
Current ratio
24.002
Quick ratio
23.446
Long term debt to equity
4.451
Total debt to equity
4.451
Interest coverage (TTM)
-59.48%
Profitability
EBITDA (TTM)
-264.398
Effective tax rate (TTM)
-0.12%
Management effectiveness
Return on assets (TTM)
-22.67%
Return on equity (TTM)
-35.83%
Valuation
Price to book
3.89
Price to tangible book (TTM)
3.89
Price to free cash flow (TTM)
-12.737
Free cash flow yield (TTM)
-7.85%
Free cash flow per share (TTM)
-5.503
Growth
Earnings per share change (TTM)
68.55%
3-year earnings per share growth (CAGR)
-15.05%
IRON News
AllArticlesVideos
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp·1 day ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp·4 days ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp·6 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs